(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

TRATAMENTO DA SEPSE E HIPERCITOCINEMIA

Em AnáliseInvention PatentPCT · SE2021050345

Application data

Number

112022020881

Type

Invention Patent

Filing

04/14/2021

Publication

11/29/2022

PCT

SE2021050345

Progress at the INPI

  1. Filing04/14/21
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 04/14/2021. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 11/29/2022. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

TX MEDIC AB

SE

Inventors

L. B. (pessoa física)

SE

Technical data

Priority claims

US

63/010,211 · 04/15/2020

Abstract

TRATAMENTO DA SEPSE E HIPERCITOCINEMIA. A invenção refere-se ao sulfato de dextrana, ou um salfarmaceuticamente aceitável do mesmo, no tratamento da sepse e hipercitocinemia.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

11/29/2022

RPI 2708

Alteração de dados cadastrais

#1.1

10/25/2022

RPI 2703

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.